Genective
Rick Emnett is currently the VP, Finance & CFO at Genective. Rick has over 17 years of experience in finance and accounting.
Rick started their career as a Senior Auditor at Brown Smith Wallace. Rick then transitioned to Corporate Finance / Pension Investments, Senior Financial Analyst at Anheuser-Busch. In 2009, they moved to The Boeing Company as a Senior Financial Analyst - Procurement. In 2013, they joined Bayer Crop Science as a Finance Manager - R&D Collaborations.
At Bayer, Rick led and developed the team that managed financial relationships with external partners with $120 million annual activity. Rick also led the creation of a parametric forecasting model that reduced full year forecast variance to 1.5%. In addition, they partnered with Monsanto IT and external consultants to implement department Oracle Hyperion EssBase reporting application, reducing reporting cycle resource requirements 20%.
Rick has a bachelor's degree in accounting from the University of Missouri - Columbia.
Rick Emnett has experience in both finance and accounting. Rick holds an MBA from Washington University in St. Louis - Olin Business School and a BS from Truman State University. Rick is also a Chartered Financial Analyst and a Certified Public Accountant.
Their manager is Qiaoni Linda Jing, CEO. Some of their coworkers include Renee Nowak - VP, Quality Management & Compliance, Erin Yarling - Senior Office Manager, and Matthew Pete - Head of Protein Biochemistry & Molecular Biology.
This person is not in any offices
Genective
Genective is a 50/50 joint venture between Limagrain and KWS, two of the world's largest seed companies. With entities and activities in North America, South America, Europe, and Asia, Genective is currently dedicated to the research, development, and commercialization of transgenic traits.